Characterization of a Neutralizing Monoclonal Antibody Directed at the Lipopolysaccharide of Chlamydia pneumoniae
Identification of protective epitopes is one of the first steps in the development of a subunit vaccine. One approach to accomplishing this is to identify structures or epitopes by using monoclonal antibodies (MAb) that can attenuate infectivity in vitro and in vivo. To date attempts to use this app...
Guardat en:
| Publicat a: | Infect Immun |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1998
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC108433/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9673271/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.66.8.3848-3855.1998 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|